Oct 2026· Frontiers in Endocrinology· Vol 17· 0 citations· 168 references
Medicine
TL;DR
This review elucidates a tripartite pathological cascade comprising organelle structural uncoupling, metabolic intermediate overflow, and epigenetic reprogramming that drives chronic intramyocellular lipid accumulation and lock the tissue in a catabolic transcriptional state.
Abstract
Type 2 diabetes mellitus (T2DM)-associated sarcopenia is driven by protein degradation and impaired myogenic regeneration. While classical models emphasize cytosolic kinase pathways, the subcellular mechanisms mediating lipotoxicity-induced chronic catabolism remain incompletely understood. This review elucidates a tripartite pathological cascade comprising organelle structural uncoupling, metabolic intermediate overflow, and epigenetic reprogramming. Chronic intramyocellular lipid accumulation disrupts lipid droplet–mitochondria contact (LDMC) sites, largely via Mfn2 modification. This spatial dissociation impairs mitochondrial oxidation, driving the nucleocytoplasmic accumulation of polar metabolites, specifically Acetyl-CoA, succinate, and lactate. Acting as covalent substrates or competitive inhibitors, these metabolites modulate histone-modifying enzymes such as p300/CBP and JmjC-domain demethylases. Consequently, this substrate-driven epigenetic remodeling increases chromatin accessibility at E3 ubiquitin ligase promoters (Atrogin-1, MuRF1) and concurrently represses myogenic loci (MyoD, MyoG), locking the tissue in a catabolic transcriptional state. Effective interventions must target this organelle-metabolite-epigenetic axis. Beyond systemic agents like SGLT2 inhibitors and GLP-1 receptor agonists, precision strategies—including repairing LDMC topology, bypassing enzymatic bottlenecks via CPT1 or LDHA, and restoring epigenetic homeostasis—are necessary to preserve lean mass and maintain skeletal muscle under metabolic stress.
Aging paradoxically leads to both a decline in skeletal muscle mitochondrial function and a shift in muscle composition that favors fibers rich in mitochondria. Yet the biological rationale and mechanism underlying this phenomenon remain largely unknown. Here we show that synthesis of the mitochondrial membrane lipid,...
In the future, integration of protein regulation, gene editing technologies, and precision therapeutic approaches may enable specific targeting of LD-mitochondria communication, thereby offering new avenues for the treatment of relevant diseases.
Yang Ding, X. Xie, Yang-Kun Li et al.· Pharmacological Research· 0 citations
Osteoarthritis (OA) is a whole-joint disease characterized by metabolic reprogramming beyond structural degeneration. Increasing evidence indicates that lipid droplets (LDs) regulate lipid storage, mobilization and intracellular lipid routing, while alterations in mitochondrial metabolism determine the capacity of chon...
Gang Meng, Rui-Jie Hou, Ping Dong et al.· Frontiers in Molecular Biosc...· 0 citations
Cellular senescence is defined by stable cell-cycle withdrawal coupled with a hyper-secretory pro-inflammatory phenotype termed the senescence-associated secretory phenotype (SASP). While canonical paradigms emphasize persistent nuclear DNA damage response (DDR) signaling as the primary driver of the SASP, increasing e...
During postnatal development, cardiomyocytes experience marked upregulation of lipid metabolism genes, which drives the transition from glycolysis to fatty acid β-oxidation (FAO). Fatty acids (FA) insufficiency hinders the maturation of induced pluripotent stem cell-derived cardiomyocytes, yet the underlying mech...
D. Guo, L. Hu, Y. Li· European Heart Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.